In the News

Press Releases and Media Coverage

May 13, 2024

Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor

Read Article
January 5, 2024

Drug Target Review: The Potential of CD24 in Cancer Immunotherapy

Read Article
November 15, 2023

Pheast Featured as One of Nature Biotechnology’s Top Academic Spinouts for 2023

Read Article
May 10, 2023

In Vivo’s 2023 Rising Leaders: Healthcare Innovators At The Top Of Their Game

Read Article
April 26, 2022

Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancer

Read Article